Could antivirals reduce your risk of long COVID? Where the research is up to on prevention and treatment

By Suman Majumdar, Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
Brendan Crabb, Director and CEO, Burnet Institute
Emma Pakula, Senior Research and Policy Officer, Burnet Institute
Michelle Scoullar, Senior Research Fellow, Burnet Institute
Ziyad Al-Aly, Director Clinical Epidemiology Center, VA St. Louis Health Care System, Washington University in St Louis

A promising collection of studies suggests taking antivirals such as Paxlovid during an infection could reduce the risk of developing long COVID.

Read complete article

~	How collaboration from across Canada, and the world, is helping fight the Alberta wildfires

~	Video game performers are becoming Hollywood stars in their own right − and are on strike to be paid and protected accordingly

~	Paris Olympics: Canada’s soccer drone scandal highlights the need for ethics education

~	World News in Brief: Historic Palestine monastery on World Heritage in Danger List, rights office condemnation as Ghana upholds anti-gay law, free jailed Russian activist

~	Nearly half of children born in Wales in 2002-3 classed as having special educational needs – this may have negatively affected their attainment

~	Bosses are increasingly forcing workers back into the office – but evidence suggests it could backfire

~	Commonly used drug may extend women’s fertility, claim researchers – here’s what you need to know about rapamycin

~	The first farmers often made landscapes more biodiverse – our research could have lessons for rewilding today

~	An artist has stolen a coin from the British Museum as part of a performance piece – but is the artwork ethical?

~	Books That Shook the Business World: The Ecology of Commerce by Paul Hawken